DXS International (LSE:DXSP) rarely troubles the headlines, so a sharp move in the shares of this AQSE-quoted healthcare-software minnow is enough to prompt the question of what, exactly, has changed. The answer is less a single dramatic catalyst than a gradual repositioning: a long-loss-making …
Diaceutics (LSE:DXRX) has spent the past year converting a long-promised strategy into harder financial numbers, and the AIM-quoted precision-medicine specialist appeared on a 27 August 2026 market screen against a backdrop of improving profitability. The Belfast-headquartered group sits at the intersection of pharmaceuticalMarketingand diagnostic …
NIOX Group (LSE:NIOX) has drifted back onto the radar of UK small-cap investors, and the reason is not hard to find: the market for point-of-care respiratory diagnostics is quietly becoming a growth story again. The AIM-listed company is the world's leading supplier of FeNO …
PureTech Health shares rose by 6.55% as investors responded to a combination of clinical momentum, portfolio validation and expectations of future value-creating events. Recent attention has centred on Celea Therapeutics and its lead respiratory programme, deupirfenidone, which is being developed for idiopathic pulmonary fibrosis.
Coiled Therapeutics shares rose as investors continued to respond positively to progress involving AO-252. The company recently dosed the first US patient with an optimised lipid-based softgel formulation designed to improve absorption and achieve more consistent exposure.
EDX Medical shares gained after the company reported further progress in the Scottish Prostate Cancer Initiative. The programme has entered another phase of testing following substantial demand during its earlier rollout. Nearly all scheduled testing events were reportedly booked rapidly, highlighting significant public appetite …
Coiled Therapeutics plc was among the London-listed healthcare stocks attracting investor attention afterLSE:COIL fell 10.53% on 26 August 2026. The decline comes at a particularly important stage in the company's development because Coiled is approaching several potentially significant clinical milestones for its lead oncology …
Eden Research plc was firmly in focus on26 August 2026 after LSE:EDEN fell 6.38%, with the shares moving to approximately2.20pas investors digested the company's newly released preliminary results for the 15 months ended 31 March 2026. The market reaction came despite several important commercial …
ProBiotix Health Plc shares were showndown 3.20% on 26 August 2026, putting LSE:PBX among the weaker-performing names in the session.
Eco Animal Health Group PLC — LSE:EAH fell0.30% on 26 August 2026, taking the shares to 98.70p.